Stratec (ETR:SBS) Shares Down 0.9% – Should You Sell?

Stratec SE (ETR:SBSGet Free Report) was down 0.9% during mid-day trading on Thursday . The stock traded as low as €27.20 ($28.63) and last traded at €27.70 ($29.16). Approximately 7,207 shares changed hands during trading, an increase of 15% from the average daily volume of 6,253 shares. The stock had previously closed at €27.95 ($29.42).

Stratec Trading Down 0.9 %

The company has a current ratio of 2.47, a quick ratio of 1.65 and a debt-to-equity ratio of 65.99. The company’s fifty day moving average is €38.40 and its 200-day moving average is €41.89. The firm has a market capitalization of $336.83 million, a P/E ratio of 23.28, a P/E/G ratio of 10.43 and a beta of 0.16.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Recommended Stories

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.